CCR2 and neoplasm: Among the chemotactic factors, chemokine (C-C Motif) ligand 2 (CCL2) is considered to be a key player in the recruitment of monocytes to the tumor, and the CCL2-CCR2 axis has been proposed as a new therapeutic target (80).